The US hopes to have immunized 100 million people against COVID-19 by the end of February, a top official said Wednesday, which is approximately 40 percent of the country’s adult population.
Each of these require two doses, the second after three weeks and four weeks, respectively.
For more coronavirus news, visit our dedicated page.
“Between mid-December, and the end of February, we will have potentially immunized 100 million people,” Moncef Slauoi, scientific advisor to the government’s Operation Warp Speed (OWS) program told reporters.
This, he continued, would cover the “at-risk” population comprising the elderly, health care workers, and first responders.
There will be an “ample” amount of vaccine to immunize three million residents of long-term care facilities, said the former pharmaceutical executive, who was recruited by the administration of President Donald Trump in May.
The rest would be enough to reach the bulk of health care workers, if states and other territories agree with federal recommendations to prioritize this population.
As production of the two vaccines expands, 20 million will be reached in December, 30 million in January and 50 million in February, making 100 million total.
This figure, however, excludes other vaccines by Johnson & Johnson and AstraZeneca-Oxford that are in the late stages of development.
Slaoui said both could produce their results between the end of December and mid-January, paving the way for emergency approval by February if the US Food and Drug Administration (FDA) gives the green light.
Slaoui added that the AstraZeneca-Oxford vaccine might be evaluated solely on the basis of a large US clinical trial involving 15,000 people, and not with data from Britain and Brazil where the data has been marred by a dosage issue.
While the Pfizer-BioNTech vaccine was approved by Britain on Wednesday, the process is slower and more public in the US.
The FDA won’t grant an emergency use authorization (EUA) before a public meeting of an advisory committee is held on December 10. For the Moderna vaccine, a similar meeting will occur on December 17.
Officials say that the logistics have been put in place to start distributing the vaccines, if approved, almost right away.
“When an EUA decision comes, distribution to the American people becomes immediate within 24 hours, that’s our goal,” said General Gus Perna, chief operating officer of OWS.
Right now he is expecting to deliver the first doses on December 15.
Trump ready to run for president in 2024 as Biden prepares to confront coronavirusDonald Trump hinted he may be ready to move on to planning another run for the US presidency in 2024 as President-elect Joe Biden prepared on ... World News
Coronavirus: Scott Atlas resigns as special adviser to US President Trump on COVID-19Dr. Scott Atlas has resigned as special adviser to President Donald Trump, a White House official said on Monday, after a controversial four months ... Coronavirus
Coronavirus: COVID-19 cases in Americas surge by 30 percent in one monthThe cumulative total of Covid-19 cases surged by nearly 30 percent across the Americas in just one month, the Pan American Health Organization warned ... Coronavirus